Owner ImaRx Therapeutics, Inc

Inventors Unger, Evan C; McCreery, Thomas P

Agent Watermark

Pub. Number AU-B-2003210631

PCT Number PCT/US03/02024

PCT Pub. Number WO2003/061593

Priority 10/055,772 23.01.02 US

Filing date 23 January 2003

Wipo publication date 2 September 2003

Acceptance publication date 1 May 2008

A61K 49/22 (2006.01) Preparations for testing - Echographic preparations

A61B 5/055 (2006.01) Measuring for diagnostic purposes - involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging

A61B 8/00 (2006.01) Diagnosis using ultrasonic, sonic or infrasonic waves

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/366 (2006.01) - having six-membered rings, e.g. delta-lactones

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/06 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Organic compounds

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 47/24 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61K 47/44 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Oils, fats or waxes according to more than one of groups

A61K 49/00 (2006.01) Preparations for testing

A61K 49/04 (2006.01) Preparations for testing - X-ray contrast preparations

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 35/00 (2006.01) Antineoplastic agents

G01R 33/28 (2006.01) Arrangements or instruments for measuring magnetic variables - Details of apparatus provided for in groups

G01T 1/161 (2006.01) Measuring X-radiation, gamma radiation, corpuscular radiation, or cosmic radiation